New cholesterol drug may be a dud

Hailed as a “game-changer” and “better than statins”, the expensive new cholesterol drug evolocumab appears to be a dud, experts conclude.

A concerted campaign in the UK is now underway to have it withdrawn from use after a fresh analysis showed the injectable medicine does not improve overall survival chances for patients with heart disease.